US Negotiates Overseas Support for Moderna Vaccine Following Pfizer Aid

[Image source=Yonhap News]

[Asia Economy Reporter Cho Hyun-ui] It has been reported that the United States is negotiating with Moderna for overseas support of the COVID-19 vaccine, following Pfizer.

On the 9th (local time), CNBC cited an anonymous official saying, "The U.S. government is negotiating to secure additional vaccines from Moderna."

The supply scale is expected to be similar to that of Pfizer. Earlier that day, The New York Times (NYT) reported that the U.S. will provide 500 million doses of the Pfizer vaccine to 100 countries from the second half of this year through the first half of next year.

Of the 500 million Pfizer vaccine doses, 200 million will be distributed within this year, and the remaining 300 million will be provided by mid-next year.

President Joe Biden is expected to announce this plan in the United Kingdom, where the Group of Seven (G7) summit will be held on the 10th.

While the U.S. has prioritized vaccinating its own citizens, it has begun sharing vaccines with the international community after reaching a certain level, with a vaccination rate exceeding 50%.

This content was produced with the assistance of AI translation services.